SyntheMol: generated antibiotic candidates against Acinetobacter baumannii
The generative model proposed about 25,000 candidates in under nine hours from more than 130,000 synthesis building blocks; of 58 synthesized, six killed a drug-resistant A. baumannii strain and two were not toxic in mice. Mechanism unknown, efficacy in infected animals untested, and four of the six compounds were not water-soluble.
Technology: SyntheMol (generative model)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Of 58 synthesized candidates, six killed a drug-resistant A. baumannii strain in the lab, and two of those were not toxic in mice.
- Still unknown: Four of the six compounds were not water-soluble so were not tested in mice, efficacy in infected animals is untested, and the mechanism is unknown.
- AI role: A generative model proposed about 25,000 candidate antibiotics and synthesis recipes in under nine hours from over 130,000 building blocks.
Evidence sources: https://med.stanford.edu/news/all-news/2024/03/ai-drug-development.html
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review date: 16 Nov 2026. Review scope: Original institutional announcement checked for the specific results, AI contribution and limitations cited in the antibiotic dossier or mathematical follow-up pilot. Full-paper reanalysis, external replication and an exhaustive follow-up search were not performed..
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 221 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.